|
HR25-00055
|
Advanced platform for targeting tumor-associated glycans
|
June Ereño
|
Asociación Centro de Investigación Cooperativa en Biociencias-CIC bioGUNE
|
Universidad del Pais Vasco (UPV/EHU); Asociación Instituto de Investigación Sanitaria Biogipuzkoa; Universitat Rovira i Virgili; Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud
|
Enabling Technologies
|
HR Consortium
|
998.670,00
|
|
HR25-00092
|
Safety, pharmacokynetics and short-term effects of oral CBD in hypoxic-ischemic newborns
|
José Martínez
|
Fundación para la Investigación Biomédica del Hospital Clínico San Carlos
|
N/A
|
Neuroscience
|
HR Single Organization
|
488.070,00
|
|
HR25-00177
|
Deciphering the contribution of common non-coding genetic variation to Autism Spectrum Disorders
|
Diogo Castro
|
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação
|
Institute of Science and Technology Austria (ISTA); The University of Auckland
|
Neuroscience
|
HR Consortium
|
731.631,00
|
|
HR25-00225
|
Liquid-walled circuits for anticoagulant-free Extra-corporeal Membrane Oxygenation
|
Thomas Hermans
|
FUNDACIÓN IMDEA NANOCIENCIA
|
Fundación para la Investigación Biomédica del Hospital Gregorio Marañón
|
Enabling Technologies
|
HR Consortium
|
999.816,40
|
|
HR25-00235
|
Going Beyond Traditional Therapies to Tailor TGF-β and SMAD Regulation in Pediatric Rare Diseases.
|
Maria J. Macias
|
Fundació Institut de Recerca Biomèdica (IRB Barcelona)
|
Universidad de Santiago de Compostela; Asociación Síndrome de Myhre España
|
Cardiovascular and associated metabolic diseases
|
HR Consortium
|
771.800,00
|
|
HR25-00241
|
High-resolution profiling of HIV-1 reservoir and immune response for revealing HIV cure
|
Ezequiel Ruiz-Mateos
|
Fundación para la Gestión de la Investigación en Salud de Sevilla
|
Fundació Institut d'Investigació Sanitària Pere Virgili; Fundació Privada Institut de Recerca Sobre Immunopatologies-Caixa IRSICAIXA; Harvard University; Projecte dels Noms-Hispanosida; Adhara Asociación VIH/Sida
|
Infectious disease
|
HR Consortium
|
999.952,40
|
|
HR25-00303
|
Assembly rules of plasmid communities in bacteria: towards predicting antimicrobial resistance
|
Alvaro San Millan
|
Agencia Estatal Consejo Superior de Investigaciones Científicas, M.P.
|
Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
|
Infectious disease
|
HR Consortium
|
989.250,00
|
|
HR25-00331
|
Transcriptional and epigenetic regulation of an anti-diabetogenic immunoregulatory cell pathway
|
Pere Santamaria
|
Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer
|
N/A
|
Cardiovascular and associated metabolic diseases
|
HR Single Organization
|
500.000,00
|
|
HR25-00392
|
Loco-radiolysed treatment for glioblastoma self-enhanced chemotherapy and targeted RNA delivery
|
Bruno Sarmento
|
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação
|
Universidade do Minho; University of Nottingham
|
Enabling Technologies
|
HR Consortium
|
989.290,00
|
|
HR25-00406
|
Human Vascularized Spinal Cord Organoid Device for Drug Discovery after traumatic injury
|
Zaida Alvarez
|
FUNDACIÓ INSTITUT DE BIOENGINYERIA DE CATALUNYA
|
Fundación Hospital Nacional de Parapléjicos para a Investigación y la Integración; Universitat de Barcelona; Institut d´Investigació Biomèdica de Bellvitge (IDIBELL); Fundación del Lesionado Medular
|
Enabling Technologies
|
HR Consortium
|
999.559,03
|
|
HR25-00415
|
Brain Integrative spatial data to generate new engineered 3D cerebral malaria models and treatments
|
Maria Bernabeu
|
Laboratorio Europeo de Biología Molecular (EMBL)
|
University of Glasgow
|
Infectious disease
|
HR Consortium
|
996.910,04
|
|
HR25-00427
|
The role of telomere transcription and TERRA in repairing broken telomeres in human cancer cells
|
Claus Maria Azzalin
|
FUNDACAO GIMM - GULBENKIAN INSTITUTE FOR MOLECULAR MEDICINE
|
N/A
|
Oncology
|
HR Single Organization
|
499.950,00
|
|
HR25-00453
|
VirusAwareScopes: Machine Learning-Driven Adaptive Microscopy for Long-Term Viral Infection Studies
|
Ricardo Henriques
|
Universidade Nova de Lisboa
|
N/A
|
Enabling Technologies
|
HR Single Organization
|
499.833,52
|
|
HR25-00456
|
Neural circuits underlying of the perception of other's emotions
|
Cristina Marquez
|
Universidade de Coimbra
|
CNRS - Centre National Recherche Scientifique
|
Neuroscience
|
HR Consortium
|
999.930,00
|
|
HR25-00467
|
Investigating Staphylococcus aureus Intracellular Lifestyle to Inform Antibiotic Selection
|
Ana Eulalio
|
Universidade de Coimbra
|
N/A
|
Infectious disease
|
HR Single Organization
|
473.902,70
|
|
HR25-00537
|
Early Risk Detection in Children with Genetic Predisposition to leukemia
|
ISIDRO SANCHEZ
|
FUNDACION DE INVESTIGACION DEL CANCER DE LA UNIVERSIDAD DE SALAMANCA
|
Agencia Estatal Consejo Superior de Investigaciones Científicas, M.P.; Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E.; Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús; Fundació Hospital Universitari Vall d´Hebron - Institut de Recerca (VHIR); FUNDACION UNO ENTRE CIEN MIL
|
Oncology
|
HR Consortium
|
1.000.000,00
|
|
HR25-00556
|
A Next-Generation Vaccine for Parkinson's Disease
|
Salvador Ventura
|
Universitat Autònoma de Barcelona (UAB)
|
Agencia Estatal Consejo Superior de Investigaciones Científicas, M.P.
|
Neuroscience
|
HR Consortium
|
628.288,00
|
|
HR25-00563
|
Innovative targeting of PAX5 in B-cell Acute Lymphoblastic Leukaemia
|
Alejandro Vaquero
|
Fundació Institut de Recerca Contra la Leucèmia Josep Carreras
|
Fundación Instituto de Investigación Sanitaria de Santiago de Compostela; FUNDACIÓN INTERNACIONAL JOSEP CARRERAS
|
Oncology
|
HR Consortium
|
989.800,00
|
|
HR25-00585
|
Anthracycline Legacy in Bone Marrow and Long-Term Cardiovascular Risks in Cancer Survivors
|
Borja Ibañez
|
Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)
|
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III; Fundación para la Investigación Biomédica del Hospital Universitario La Paz
|
Cardiovascular and associated metabolic diseases
|
HR Consortium
|
999.500,00
|
|
HR25-00662
|
ARI-007, a CART anti-CD7 for patients with relapsed-refractory T cell acute lymphoid leukemia
|
Alvaro Urbano
|
Fundació de Recerca Clínic Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer
|
Fundació Privada per a la Recerca i la Docència Sant Joan de Déu
|
Oncology
|
HR Consortium
|
996.024,00
|
|
HR25-00781
|
Therapeutic OligonUCleotides Activated by Nucleases: Targeted antibiotics for bacterial infections
|
Frank J. Hernandez
|
Universidad de Navarra - Universidad de Navarra
|
Medical University of Vienna
|
Infectious disease
|
HR Consortium
|
995.000,00
|
|
HR25-00804
|
Discovering moonlighting activities of antimicrobial resistance genes .
|
José Antonio Escudero
|
Universidad Complutense de Madrid
|
N/A
|
Infectious disease
|
HR Single Organization
|
499.570,00
|
|
HR25-00813
|
Improving gene therapy for life-threatening heart conditions
|
Juan Antonio Bernal
|
Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)
|
N/A
|
Cardiovascular and associated metabolic diseases
|
HR Single Organization
|
498.352,00
|
|
HR25-00814
|
Uncovering new mechanisms involved in the resolution of adipose tissue meta-inflammation
|
Josep A. Villena
|
Fundació Hospital Universitari Vall d´Hebron - Institut de Recerca (VHIR)
|
N/A
|
Cardiovascular and associated metabolic diseases
|
HR Single Organization
|
499.700,00
|
|
HR25-00861
|
Advancing Precision Oncology through the Tumor Microenvironment Analysis
|
Alexandre Calon
|
Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM)
|
Universidad de Oviedo; Universidad de Granada; Consorcio para la explotación del Centro Nacional de Análisis Genómico
|
Oncology
|
HR Consortium
|
996.750,00
|
|
HR25-00880
|
Tuning neurons by controlling brain cell metabolism using MIcroenvironment sensitive Nanosystems
|
Ana Paula Gomes Moreira Pêgo
|
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação
|
Fundación Instituto de Investigación Sanitaria de Santiago de Compostela; Tel Aviv University; PT.AVC - União de Sobreviventes, Familiares e Amigos; Fundacio Ictus
|
Enabling Technologies
|
HR Consortium
|
999.563,80
|
|
HR25-00886
|
Study of the Impact of the Tumor Microenvironment on Immunotherapy in Glioblastoma
|
Joan Seoane
|
Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)
|
N/A
|
Oncology
|
HR Single Organization
|
497.992,96
|
|
HR25-00908
|
Discovery and Multidimensional Characterization of Novel Microglia Regulators in ALS
|
Cintia Roodveldt
|
Universidad de Sevilla
|
Fundación Canaria Instituto de Investigación Sanitaria de Canarias; Agencia Estatal Consejo Superior de Investigaciones Científicas, M.P.
|
Neuroscience
|
HR Consortium
|
770.000,00
|
|
HR25-00930
|
KCNB1-related developmental and epileptic encephalopathy: towards personalized therapies
|
ANTONIO FERRER
|
Universidad Miguel Hernández de Elche
|
Fundación para la Investigación Biomédica del Hospital Infantil Universitario Niño Jesús
|
Neuroscience
|
HR Consortium
|
797.525,00
|
|
HR25-00954
|
Targeting microexons and neural-related splicing programs to enhance in vitro beta cell maturation
|
Manuel Irimia
|
Universitat Pompeu Fabra (UPF)
|
Fundació Centre de Regulació Genòmica (CRG); Max-Delbrück-Center for Molecular Medicine (MDC)
|
Cardiovascular and associated metabolic diseases
|
HR Consortium
|
999.847,40
|
|
HR25-00965
|
Dopamine, impulsivity, and multi-scale, hierarchical control of behavior
|
Joseph Paton
|
Fundação D. Anna Sommer Champalimaud e Dr. Carlos Montez Champalimaud
|
N/A
|
Neuroscience
|
HR Single Organization
|
497.860,00
|
|
HR25-01094
|
Metabolic organ crosstalk in cancer-induced cachexia as a novel therapeutic approach
|
Miguel López
|
Universidad de Santiago de Compostela
|
Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)
|
Cardiovascular and associated metabolic diseases
|
HR Consortium
|
999.300,00
|
|
HR25-01153
|
Lipid droplets as immunometabolic mediators in mitochondrial disease encephalopathy
|
Albert Quintana
|
Universitat Autònoma de Barcelona (UAB)
|
N/A
|
Neuroscience
|
HR Single Organization
|
499.970,00
|
|
HR25-01192
|
Development of CAR T cell therapies against cancer-specific post-translational modifications
|
João Lacerda
|
FUNDACAO GIMM - GULBENKIAN INSTITUTE FOR MOLECULAR MEDICINE
|
N/A
|
Oncology
|
HR Single Organization
|
499.303,00
|
